Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Providing free continuous glucose monitors to improve diabetes management

Official title: CGMs for All: Studying the Impact of Expanding CGM Access

Run by Yale University · NCT06658067 · Data updated 2026-11-12

This study is testing if giving free continuous glucose monitors to adults with poorly controlled type 2 diabetes can help them manage their blood sugar better and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment17 (estimated)
SponsorYale University
Academic / other
Locations1 site (New Haven, Connecticut)
StatusRecruiting
StartedNovember 12, 2024
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedDecember 3, 2025
Trial IDNCT06658067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with type 2 diabetes, an A1c of 8.0 or greater, and who are unable to afford continuous glucose monitors.

Probably not a fit

Patients who have well-controlled diabetes or those who can afford CGM sensors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effects of providing continuous glucose monitors (CGMs) at no cost to adult patients with poorly controlled type 2 diabetes. Participants will be selected from Fair Haven Community Health Care and must have an A1c of 8.0 or greater while being unable to afford CGM sensors. The study will assess changes in glycemic control and quality of life over a 12-week period, with follow-up visits to adjust medication based on CGM data. The goal is to determine if access to CGMs can improve health outcomes for economically disadvantaged patients.

Why it matters

Potential benefit: If successful, this study could significantly enhance glycemic control and quality of life for patients with type 2 diabetes who currently lack access to necessary monitoring tools.

How similar studies have gone: Other studies have shown positive outcomes with similar interventions, indicating that providing CGMs can improve diabetes management in underserved populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Diagnosed with type 2 diabetes mellitus
* A1c greater than or equal to 8.0 within two weeks of the time of enrollment
* On insulin for at least one year +/- other antihyperglycemics
* Ability and willingness to wear CGM for 14-day periods throughout the trial period
* Ability and willingness to comply with provider-directed adjustments to medication regimen
* Inability to afford CGM sensors

A note on Vulnerable Populations: Many of FHCHC's patients are economically disadvantaged and of minority backgrounds; the clinic's patient base may be considered to constitute a vulnerable population. As such, recruitment and enrollment will be conducted within a vulnerable population. The nature of the study requires this, and the results are intended to directly benefit this population through the potential for improved glycemic control and quality of life.

Exclusion Criteria:

* Insulin naïve
* Diabetic ketoacidosis (DKA) in previous 6 months
* End-Stage Renal Disease (ESRD)
* Contraindications to CGM use
* Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
* Pregnancy

Where it's running

  • Fair Haven Community Health Care (FHCHC)
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.